Howard Hassman, DO

  • 3Articles
  • 7.4KReads
  • 1998–2025Active
  • 24Collaborators
  • 1Citations

About

Howard Hassman, DO, is affiliated with the Hassman Research Institute in Marlton, New Jersey. His publications span from 1998 to 2025 and focus on major depressive disorder and bipolar disorder. He has authored studies on novel treatments for treatment-resistant depression, cognitive effects of antipsychotics in bipolar I disorder, and antidepressant use in elderly patients. His work has appeared in Psychiatrist.com, including The Journal of Clinical Psychiatry and The Primary Care Companion for CNS Disorders.

Publications

JCP
Onfasprodil (MIJ821) in Patients with Treatment-Resistant Depression: A Phase 2, Randomized, Placebo-Controlled, Proof-of-Concept Study
Original Research

Onfasprodil (MIJ821) in Patients with Treatment-Resistant Depression: A Phase 2, Randomized, Placebo-Controlled, Proof-of-Concept Study

August 6, 2025

Onfasprodil appeared to be effective and well-tolerated across all dosing regimens in patients with TRD and demonstrated rapid onset of action (24 hours) with evidence of antidepressant effects to...
, , , et al
JCP
Original Research

Cognitive Functioning and Acute Sedative Effects of Risperidone and Quetiapine in Patients With Stable Bipolar I Disorder: A Randomized, Double-Blind, Crossover Study

August 15, 2007

, , , et al
JCP
Original Research

Buspirone and Imipramine for the Treatment of Major Depression in the Elderly

April 15, 1998

, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe